scholarly journals Retrospective evaluation of the use of the International Myeloma Working Group response criteria in dogs with secretory multiple myeloma

2020 ◽  
Author(s):  
A Russell Moore ◽  
Adam Harris ◽  
Christina Jeffries ◽  
Paul R. Avery ◽  
Kate Vickery
Keyword(s):  
Multiple Myeloma ◽  
Working Group ◽  
Response Criteria ◽  
Retrospective Evaluation ◽  
Group Response ◽  
International Myeloma Working Group

Quantification of bone-marrow plasma cell levels using various International Myeloma Working Group response criteria in patients with multiple myeloma

2018 ◽  
Vol 108 (4) ◽  
pp. 371-374 ◽  
Author(s):  
Kentaro Narita ◽  
Hiroki Kobayashi ◽  
Yoshiaki Abe ◽  
Hiroaki Kitadate ◽  
Masami Takeuchi ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Bone Marrow ◽  
Plasma Cell ◽  
Working Group ◽  
Response Criteria ◽  
Group Response ◽  
Bone Marrow Plasma ◽  
International Myeloma Working Group

scholarly journals International Myeloma Working Group response criteria

2019 ◽  
Author(s):  
Patrick Rock ◽  
Francis Deng
Keyword(s):  
Working Group ◽  
Response Criteria ◽  
Group Response ◽  
International Myeloma Working Group

scholarly journals International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

Leukemia ◽  
2009 ◽  
Vol 23 (9) ◽  
pp. 1545-1556 ◽  
Author(s):  
M Dimopoulos ◽  
◽  
E Terpos ◽  
R L Comenzo ◽  
P Tosi ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Working Group ◽  
Consensus Statement ◽  
Imaging Techniques ◽  
Group Consensus ◽  
Current Role ◽  
International Myeloma Working Group

scholarly journals Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Leukemia ◽  
2012 ◽  
Vol 26 (5) ◽  
pp. 1153-1153 ◽  
Author(s):  
S K Kumar ◽  
◽  
J H Lee ◽  
J J Lahuerta ◽  
G Morgan ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Working Group ◽  
Risk Of Progression ◽  
International Myeloma Working Group

scholarly journals International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease

2013 ◽  
Vol 31 (18) ◽  
pp. 2347-2357 ◽  
Author(s):  
Evangelos Terpos ◽  
Gareth Morgan ◽  
Meletios A. Dimopoulos ◽  
Matthew T. Drake ◽  
Suzanne Lentzsch ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Multiple Myeloma ◽  
Spinal Cord Compression ◽  
Bone Disease ◽  
Working Group ◽  
Cord Compression ◽  
Vertebral Compression Fractures ◽  
Bone Lesions ◽  
Published Data ◽  
International Myeloma Working Group

PurposeThe aim of the International Myeloma Working Group was to develop practice recommendations for the management of multiple myeloma (MM) –related bone disease.MethodologyAn interdisciplinary panel of clinical experts on MM and myeloma bone disease developed recommendations based on published data through August 2012. Expert consensus was used to propose additional recommendations in situations where there were insufficient published data. Levels of evidence and grades of recommendations were assigned and approved by panel members.RecommendationsBisphosphonates (BPs) should be considered in all patients with MM receiving first-line antimyeloma therapy, regardless of presence of osteolytic bone lesions on conventional radiography. However, it is unknown if BPs offer any advantage in patients with no bone disease assessed by magnetic resonance imaging or positron emission tomography/computed tomography. Intravenous (IV) zoledronic acid (ZOL) or pamidronate (PAM) is recommended for preventing skeletal-related events in patients with MM. ZOL is preferred over oral clodronate in newly diagnosed patients with MM because of its potential antimyeloma effects and survival benefits. BPs should be administered every 3 to 4 weeks IV during initial therapy. ZOL or PAM should be continued in patients with active disease and should be resumed after disease relapse, if discontinued in patients achieving complete or very good partial response. BPs are well tolerated, but preventive strategies must be instituted to avoid renal toxicity or osteonecrosis of the jaw. Kyphoplasty should be considered for symptomatic vertebral compression fractures. Low-dose radiation therapy can be used for palliation of uncontrolled pain, impending pathologic fracture, or spinal cord compression. Orthopedic consultation should be sought for long-bone fractures, spinal cord compression, and vertebral column instability.

scholarly journals New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

Leukemia ◽  
2013 ◽  
Vol 28 (3) ◽  
pp. 525-542 ◽  
Author(s):  
E M Ocio ◽  
◽  
P G Richardson ◽  
S V Rajkumar ◽  
A Palumbo ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Working Group ◽  
Mechanisms Of Action ◽  
New Drugs ◽  
International Myeloma Working Group

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

2016 ◽  
Vol 17 (8) ◽  
pp. e328-e346 ◽  
Author(s):  
Shaji Kumar ◽  
Bruno Paiva ◽  
Kenneth C Anderson ◽  
Brian Durie ◽  
Ola Landgren ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Minimal Residual Disease ◽  
Working Group ◽  
Residual Disease ◽  
Disease Assessment ◽  
Group Consensus ◽  
Minimal Residual ◽  
International Myeloma Working Group

scholarly journals International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

Leukemia ◽  
2008 ◽  
Vol 23 (2) ◽  
pp. 215-224 ◽  
Author(s):  
A Dispenzieri ◽  
◽  
R Kyle ◽  
G Merlini ◽  
J S Miguel ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Light Chain ◽  
Working Group ◽  
Free Light Chain ◽  
Serum Free ◽  
Serum Free Light Chain ◽  
Chain Analysis ◽  
International Myeloma Working Group

scholarly journals Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Leukemia ◽  
2011 ◽  
Vol 26 (1) ◽  
pp. 149-157 ◽  
Author(s):  
S K Kumar ◽  
◽  
J H Lee ◽  
J J Lahuerta ◽  
G Morgan ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Working Group ◽  
Risk Of Progression ◽  
International Myeloma Working Group
Sign in / Sign up

Export Citation Format

Share Document